Literature DB >> 18802314

Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation.

Pirjo Valtonen1, Tomi Laitinen, Tiina Lyyra-Laitinen, Olli T Raitakari, Markus Juonala, Jorma S A Viikari, Nonna Heiskanen, Esko Vanninen, Kari Punnonen, Seppo Heinonen.   

Abstract

BACKGROUND: Normal pregnancy is associated with enhanced vasodilatation because of the increased nitric oxide (NO) production. Because L-homoarginine can act as a substrate for NO production, concentrations of L-homoarginine in normal pregnancy were assessed in the present study to test whether L-homoarginine is associated with endothelial function. METHODS AND
RESULTS: Healthy non-pregnant (n=61) and pregnant women (n=58) were studied in a cross-sectional study. L-homoarginine, L-arginine, asymmetric dimethylarginine and symmetric dimethylarginine concentrations were determined simultaneously by high-performance liquid chromatography. Endothelium-dependent brachial artery flow-mediated dilation (FMD) was measured by ultrasound. The serum L-homoarginine concentration was significantly higher during the second and the third trimesters compared with the levels in the non-pregnant women (4.8+/-1.7 and 5.3+/-1.5 vs 2.7+/-1.0 micromol/L, p<0.001, respectively). In line with this, FMD increased in response to pregnancy (p<0.05). Three months after delivery, the L-homoarginine concentrations and FMD were comparable to those recorded in the non-pregnant females. The concentration of L-homoarginine correlated significantly with gestational age (r=0.426, p=0.001) and brachial artery diameter and FMD (r=0.362, p=0.006 and r=0.306, p=0.022, respectively) in pregnancy.
CONCLUSIONS: L-homoarginine appears to be increased during the second and third trimesters of pregnancy and may contribute to the enhanced endothelial function in normal pregnancies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802314     DOI: 10.1253/circj.cj-08-0240

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  26 in total

1.  Homoarginine deficiency is associated with increased bone turnover.

Authors:  S Pilz; A Meinitzer; A Tomaschitz; K Kienreich; A Fahrleitner-Pammer; C Drechsler; B O Boehm; W März
Journal:  Osteoporos Int       Date:  2012-04-14       Impact factor: 4.507

2.  Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice.

Authors:  Ozgur Gunduz; Cetin Hakan Karadag; Ahmet Ulugol
Journal:  J Neural Transm (Vienna)       Date:  2010-07-27       Impact factor: 3.575

3.  Oral supplementation with L-homoarginine in young volunteers.

Authors:  Dorothee Atzler; Mirjam Schönhoff; Kathrin Cordts; Imke Ortland; Julia Hoppe; Friedhelm C Hummel; Christian Gerloff; Ulrich Jaehde; Annika Jagodzinski; Rainer H Böger; Chi-Un Choe; Edzard Schwedhelm
Journal:  Br J Clin Pharmacol       Date:  2016-09-20       Impact factor: 4.335

4.  Associations of homoarginine with bone metabolism and density, muscle strength and mortality: cross-sectional and prospective data from 506 female nursing home patients.

Authors:  S Pilz; A Meinitzer; A Tomaschitz; K Kienreich; H Dobnig; M Schwarz; D Wagner; C Drechsler; C Piswanger-Sölkner; W März; A Fahrleitner-Pammer
Journal:  Osteoporos Int       Date:  2012-03-17       Impact factor: 4.507

5.  Metabolic signatures of pregnancy-induced cardiac growth.

Authors:  Kyle L Fulghum; Juliette B Smith; Julia Chariker; Lauren F Garrett; Kenneth R Brittian; Pawel K Lorkiewicz; Lindsey A McNally; Shizuka Uchida; Steven P Jones; Bradford G Hill; Helen E Collins
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-05-27       Impact factor: 5.125

6.  Evaluation of salivary and serum methylated arginine metabolites and nitric oxide synthase in advanced periodontitis patients.

Authors:  Volkan Şengül; Zeliha Güney; Şivge Kurgan; Canan Önder; Muhittin A Serdar; Meral Günhan
Journal:  Clin Oral Investig       Date:  2022-04-14       Impact factor: 3.606

7.  Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients.

Authors:  Christiane Drechsler; Andreas Meinitzer; Stefan Pilz; Vera Krane; Andreas Tomaschitz; Eberhard Ritz; Winfried März; Christoph Wanner
Journal:  Eur J Heart Fail       Date:  2011-08       Impact factor: 15.534

8.  Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patients.

Authors:  Pietro Ravani; Renke Maas; Fabio Malberti; Paola Pecchini; Maren Mieth; Robert Quinn; Giovanni Tripepi; Francesca Mallamaci; Carmine Zoccali
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

9.  Lessons from neurolathyrism: a disease of the past & the future of Lathyrus sativus (Khesari dal).

Authors:  Surya S Singh; S L N Rao
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

10.  Homoarginine and progression of chronic kidney disease: results from the Mild to Moderate Kidney Disease Study.

Authors:  Christiane Drechsler; Barbara Kollerits; Andreas Meinitzer; Winfried März; Eberhard Ritz; Paul König; Ulrich Neyer; Stefan Pilz; Christoph Wanner; Florian Kronenberg
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.